These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
592 related articles for article (PubMed ID: 31776268)
1. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes. Lo Cigno I; Calati F; Borgogna C; Zevini A; Albertini S; Martuscelli L; De Andrea M; Hiscott J; Landolfo S; Gariglio M J Virol; 2020 Jan; 94(4):. PubMed ID: 31776268 [TBL] [Abstract][Full Text] [Related]
2. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling. Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274 [TBL] [Abstract][Full Text] [Related]
3. Subversion of Host Innate Immunity by Human Papillomavirus Oncoproteins. Lo Cigno I; Calati F; Albertini S; Gariglio M Pathogens; 2020 Apr; 9(4):. PubMed ID: 32316236 [TBL] [Abstract][Full Text] [Related]
4. Activation of telomerase by HPVs. Katzenellenbogen RA Virus Res; 2017 Mar; 231():50-55. PubMed ID: 27863966 [TBL] [Abstract][Full Text] [Related]
5. The human papillomavirus E7 oncoprotein as a regulator of transcription. Songock WK; Kim SM; Bodily JM Virus Res; 2017 Mar; 231():56-75. PubMed ID: 27818212 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control. Pacini L; Savini C; Ghittoni R; Saidj D; Lamartine J; Hasan UA; Accardi R; Tommasino M J Virol; 2015 Nov; 89(22):11396-405. PubMed ID: 26339055 [TBL] [Abstract][Full Text] [Related]
7. HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ Albertini S; Lo Cigno I; Calati F; De Andrea M; Borgogna C; Dell'Oste V; Landolfo S; Gariglio M J Immunol; 2018 Mar; 200(6):2076-2089. PubMed ID: 29386255 [TBL] [Abstract][Full Text] [Related]
8. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells. Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395 [TBL] [Abstract][Full Text] [Related]
9. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. Strickland SW; Vande Pol S J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265 [TBL] [Abstract][Full Text] [Related]
10. The role of HPV11 E7 in modulating STING-dependent interferon β response in recurrent respiratory papillomatosis. Chen L; Hu H; Pan Y; Lu Y; Zhao M; Zhao Y; Wang L; Liu K; Yu Z J Virol; 2024 May; 98(5):e0192523. PubMed ID: 38624230 [TBL] [Abstract][Full Text] [Related]
11. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation. Hatterschide J; Brantly AC; Grace M; Munger K; White EA J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101 [TBL] [Abstract][Full Text] [Related]
12. The human papillomavirus (HPV) E7 protein antagonises an Imiquimod-induced inflammatory pathway in primary human keratinocytes. Richards KH; Wasson CW; Watherston O; Doble R; Eric Blair G; Wittmann M; Macdonald A Sci Rep; 2015 Aug; 5():12922. PubMed ID: 26268216 [TBL] [Abstract][Full Text] [Related]
13. High-risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects. Lo Cigno I; Calati F; Girone C; Catozzo M; Gariglio M J Med Virol; 2024 Jun; 96(6):e29685. PubMed ID: 38783790 [TBL] [Abstract][Full Text] [Related]
14. Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. Hong S; Mehta KP; Laimins LA J Virol; 2011 Sep; 85(18):9486-94. PubMed ID: 21734056 [TBL] [Abstract][Full Text] [Related]
15. Human papillomaviruses target the double-stranded RNA protein kinase pathway. Hebner CM; Wilson R; Rader J; Bidder M; Laimins LA J Gen Virol; 2006 Nov; 87(Pt 11):3183-3193. PubMed ID: 17030851 [TBL] [Abstract][Full Text] [Related]
16. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14. Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D mBio; 2016 May; 7(3):. PubMed ID: 27143385 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation. Mittal S; Banks L Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687 [TBL] [Abstract][Full Text] [Related]
18. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53. Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506 [TBL] [Abstract][Full Text] [Related]
19. West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5. Zhang HL; Ye HQ; Liu SQ; Deng CL; Li XD; Shi PY; Zhang B J Virol; 2017 Sep; 91(18):. PubMed ID: 28659477 [TBL] [Abstract][Full Text] [Related]
20. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis. Wei T; Grace M; Uberoi A; Romero-Masters JC; Lee D; Lambert PF; Munger K mBio; 2021 Aug; 12(4):e0227721. PubMed ID: 34465025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]